The Latin America, Middle East and Africa Neurovascular Devices Market should witness market growth of 12.3% CAGR during the forecast period (2022-2028).
Clinical specialists and neurosurgeons are increasingly examining therapeutic options that can significantly lower the risk of patient fatality or catastrophic neurovascular illnesses. In addition, the demand for potent neurovascular therapeutics is steadily expanding due to the growing population of patients suffering from neurovascular diseases and the increasing severity of the diseases in the target population.
When a blood clot restricts blood flow to the brain, starving it of oxygen and blood, clot removal items called neuro thrombectomy devices are utilized to treat ischemic stroke. Mechanical thrombectomy, where a specialist mechanically removes a clot via clot retrievers or suction equipment, is the first-line treatment for ischemic stroke. This procedure also includes thrombolytic therapy, wherein medication is given to dissolve the clot.
In Israel, stroke is third on the list of leading causes of death. In 2013, 5.6% of all deaths in Israel resulted from a stroke. In addition to mortality, the most significant consequence of a stroke is long-term impairment, particularly among the elderly. Around 15,000 strokes occur each year in Israel, according to national survey figures. Ischemic strokes, caused by blockage of cerebral blood arteries, account for approximately 85% of all strokes. In addition, 15% are hemorrhagic strokes caused by a ruptured blood artery that bleeds into the brain tissue. The primary risk factor for stroke is high blood pressure, which is particularly prevalent in the older population. The growing incidence of strokes and R&D efforts are predicted to support the regional market’s growth.
The Brazil market dominated the LAMEA Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $93.1 million by 2028. The Argentina market is experiencing a CAGR of 12.9% during (2022-2028). Additionally, The UAE market would display a CAGR of 12% during (2022-2028).
Based on End-user, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
Clinical specialists and neurosurgeons are increasingly examining therapeutic options that can significantly lower the risk of patient fatality or catastrophic neurovascular illnesses. In addition, the demand for potent neurovascular therapeutics is steadily expanding due to the growing population of patients suffering from neurovascular diseases and the increasing severity of the diseases in the target population.
When a blood clot restricts blood flow to the brain, starving it of oxygen and blood, clot removal items called neuro thrombectomy devices are utilized to treat ischemic stroke. Mechanical thrombectomy, where a specialist mechanically removes a clot via clot retrievers or suction equipment, is the first-line treatment for ischemic stroke. This procedure also includes thrombolytic therapy, wherein medication is given to dissolve the clot.
In Israel, stroke is third on the list of leading causes of death. In 2013, 5.6% of all deaths in Israel resulted from a stroke. In addition to mortality, the most significant consequence of a stroke is long-term impairment, particularly among the elderly. Around 15,000 strokes occur each year in Israel, according to national survey figures. Ischemic strokes, caused by blockage of cerebral blood arteries, account for approximately 85% of all strokes. In addition, 15% are hemorrhagic strokes caused by a ruptured blood artery that bleeds into the brain tissue. The primary risk factor for stroke is high blood pressure, which is particularly prevalent in the older population. The growing incidence of strokes and R&D efforts are predicted to support the regional market’s growth.
The Brazil market dominated the LAMEA Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $93.1 million by 2028. The Argentina market is experiencing a CAGR of 12.9% during (2022-2028). Additionally, The UAE market would display a CAGR of 12% during (2022-2028).
Based on End-user, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
Scope of the Study
By End-user
- Hospital & Surgery Centers
- Ambulatory Care Centers
- Research laboratories & Academic Institutes
By Technology
- Embolization & Coiling
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Neurothrombectomy Devices
- Clot Retrievers
- Suction & Aspiration Devices
- Snares
- Cerebral Balloon Angioplasty & Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
- Support Devices
- Microcatheters
- Microguidewires
By Disease Pathology
- Cerebral Aneuryms
- Ischemic Strokes
- Cartoid Artery Stenosis
- Arteriovenous Malformation & Fistulas (AVM)
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Medtronic PLC
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Medikit Co. Ltd.
- W. L. Gore & Associates, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Neurovascular Devices Market by End-user
Chapter 4. LAMEA Neurovascular Devices Market by Technology
Chapter 5. LAMEA Neurovascular Devices Market by Disease Pathology
Chapter 6. LAMEA Neurovascular Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Medikit Co. Ltd.
- W. L. Gore & Associates, Inc.
Methodology
LOADING...
Related Reports
Neurovascular Devices Market by Disease Pathology, Devices, End-User - Global Forecast 2025-2030
- Report
- 184 Pages
- Global
From
Neurovascular Devices / Interventional Neurology - Global Strategic Business Report
- Report
- 179 Pages
- Global
From
Neurovascular Device Market
- Report
- 200 Pages
- Global
From
From
Neurovascular Devices Market Report by Product, End User, and Region 2024-2032
- Report
- 141 Pages
- Global
From
About the Market
The Neurovascular Device market is a subset of the Neurology Devices market, which focuses on the diagnosis and treatment of neurological disorders. Neurovascular Devices are used to treat conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are used to restore blood flow to the brain, reduce the risk of stroke, and improve patient outcomes. Neurovascular Devices include stents, embolic coils, flow diverters, and occlusion balloons. These devices are used in a variety Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
